Menicon Co., Ltd. (7780.T)
JPY 1437.0
(-1.91%)
JPY 1437.0
(-1.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 16.9 Billion JPY | -13.41% |
| 2022 | 19.51 Billion JPY | 10.82% |
| 2021 | 17.25 Billion JPY | 20.6% |
| 2020 | 14.13 Billion JPY | 20.06% |
| 2019 | 12.45 Billion JPY | 16.28% |
| 2018 | 10.21 Billion JPY | 7.67% |
| 2017 | 9.4 Billion JPY | 8.78% |
| 2016 | 9.07 Billion JPY | 11.99% |
| 2015 | 8.44 Billion JPY | 8.75% |
| 2014 | 7.32 Billion JPY | 10.49% |
| 2013 | 6.73 Billion JPY | 12623.34% |
| 2012 | -53 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.66 Billion JPY | 36.92% |
| 2023 Q4 | 3.53 Billion JPY | 43.19% |
| 2023 Q3 | 2.46 Billion JPY | -8.73% |
| 2023 Q2 | 2.7 Billion JPY | 7.22% |
| 2023 Q1 | 2.52 Billion JPY | 81.96% |
| 2023 FY | - JPY | -13.41% |
| 2022 Q1 | 3.39 Billion JPY | 73.16% |
| 2022 Q4 | 1.38 Billion JPY | -64.52% |
| 2022 FY | - JPY | 10.82% |
| 2022 Q3 | 3.9 Billion JPY | 15.43% |
| 2022 Q2 | 3.38 Billion JPY | -0.29% |
| 2021 Q2 | 2.55 Billion JPY | -4.14% |
| 2021 Q4 | 1.96 Billion JPY | -37.76% |
| 2021 FY | - JPY | 20.6% |
| 2021 Q1 | 2.66 Billion JPY | 119.83% |
| 2021 Q3 | 3.14 Billion JPY | 23.49% |
| 2020 Q3 | 2.52 Billion JPY | -5.83% |
| 2020 FY | - JPY | 20.06% |
| 2020 Q4 | 1.21 Billion JPY | -51.98% |
| 2020 Q2 | 2.67 Billion JPY | 23.32% |
| 2020 Q1 | 2.17 Billion JPY | 251.13% |
| 2019 Q2 | 2.71 Billion JPY | 40.35% |
| 2019 Q4 | 618 Million JPY | -58.22% |
| 2019 Q3 | 1.47 Billion JPY | -45.48% |
| 2019 Q1 | 1.93 Billion JPY | 52.44% |
| 2019 FY | - JPY | 16.28% |
| 2018 Q3 | 1.56 Billion JPY | -7.84% |
| 2018 Q2 | 1.69 Billion JPY | 31.07% |
| 2018 FY | - JPY | 7.67% |
| 2018 Q1 | 1.29 Billion JPY | 2021.31% |
| 2018 Q4 | 1.26 Billion JPY | -18.87% |
| 2017 FY | - JPY | 8.78% |
| 2017 Q1 | 1.53 Billion JPY | 82.83% |
| 2017 Q4 | 61 Million JPY | -95.27% |
| 2017 Q2 | 1.82 Billion JPY | 19.19% |
| 2017 Q3 | 1.29 Billion JPY | -29.35% |
| 2016 Q3 | 1.28 Billion JPY | 22.45% |
| 2016 Q1 | 1.09 Billion JPY | 32739.01% |
| 2016 FY | - JPY | 11.99% |
| 2016 Q4 | 837.93 Million JPY | -35.03% |
| 2016 Q2 | 1.05 Billion JPY | -3.9% |
| 2015 Q3 | 1.16 Billion JPY | -21.25% |
| 2015 Q4 | -3.35 Million JPY | -100.29% |
| 2015 FY | - JPY | 8.75% |
| 2015 Q1 | 974.89 Million JPY | -16.72% |
| 2015 Q2 | 1.47 Billion JPY | 51.45% |
| 2014 Q4 | 1.17 Billion JPY | 0.0% |
| 2014 FY | - JPY | 10.49% |
| 2013 FY | - JPY | 12623.34% |
| 2012 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| JINS HOLDINGS Inc. | 10.26 Billion JPY | -64.717% |
| Medius Holdings Co., Ltd. | 3.86 Billion JPY | -337.488% |
| Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 46.992% |
| JTEC Corporation | 437.18 Million JPY | -3765.685% |
| Hogy Medical Co.,Ltd. | 10.77 Billion JPY | -56.83% |
| Kawamoto Corporation | 944.44 Million JPY | -1689.405% |
| Terumo Corporation | 219.66 Billion JPY | 92.306% |
| KAINOS Laboratories, Inc. | 1.05 Billion JPY | -1500.714% |
| JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | -226.066% |
| Sysmex Corporation | 115.67 Billion JPY | 85.39% |
| JMS Co.,Ltd. | 3.44 Billion JPY | -390.424% |
| Nakanishi Inc. | 32.3 Billion JPY | 47.679% |
| Mani, Inc. | 10.69 Billion JPY | -57.959% |
| Olympus Corporation | 180.16 Billion JPY | 90.62% |
| HOYA Corporation | 260.44 Billion JPY | 93.511% |
| SEED Co.,Ltd. | 4.88 Billion JPY | -246.273% |
| Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 46.947% |
| Medikit Co.,Ltd. | 6.31 Billion JPY | -167.413% |
| Daiken Medical Co., Ltd. | 1.65 Billion JPY | -919.65% |
| Sincere Co., LTD. | 391 Million JPY | -4222.251% |
| Platz Co., Ltd. | 267.15 Million JPY | -6225.987% |
| Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 27.806% |
| Shofu Inc. | 5.87 Billion JPY | -187.513% |
| Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -1120.001% |
| Nipro Corporation | 81.2 Billion JPY | 79.189% |
| ASO International, Inc. | 602.47 Million JPY | -2705.1% |